Pier Paolo Di Fiore - Cell Biology

Author Information

Pier Paolo Di Fiore is a distinguished researcher affiliated with the Istituto Europeo di Oncologia in Milan, Italy. His work primarily focuses on cancer biology, with significant contributions to the understanding of breast cancer mechanisms, metastasis, and the role of endocytosis in cancer progression. His research aims to bridge the gap between basic science and clinical applications, providing insights that could lead to improved cancer therapies and diagnostic tools.

Research Contributions

Dr. Pier Paolo Di Fiore has made substantial contributions to cancer research, particularly in breast cancer. His recent work includes comparing genomic predictors such as StemPrintER and Oncotype DX for assessing breast cancer recurrence risk. He has also explored the mechanisms driving metastasis in breast cancer and the role of phosphoinositide conversion in these processes. Moreover, his studies on the gut vascular barrier and its implications for colorectal cancer metastasis to the liver highlight his diverse research interests within the oncology field.

Aliases

Pier Paolo Di Fiore is known by several aliases, including P P Di Fiore, P. P. Di Fiore, and P.p. Di Fiore. These variations are used across different publications and databases, but all refer to the same researcher.

Publication and Citation Metrics

Metric	Value
Total Citation Count	14,679
h-index	69
Total Number of Papers	185

Publications:

Comparison of StemPrintER with Oncotype DX Recurrence Score for predicting risk of breast cancer distant recurrence after endocrine therapy.

DOI: 10.1016/j.ejca.2022.01.003

Year: 2022

Phosphoinositide Conversion Inactivates R‐RAS and Drives Metastases in Breast Cancer

DOI: 10.1002/advs.202103249

Year: 2022

miR-146 connects stem cell identity with metabolism and pharmacological resistance in breast cancer

DOI: 10.1083/jcb.202009053

Year: 2021

Gut vascular barrier impairment leads to intestinal bacteria dissemination and colorectal cancer metastasis to liver.

DOI: 10.1016/j.ccell.2021.03.004

Year: 2021

Endocytosis in the context-dependent regulation of individual and collective cell properties

DOI: 10.1038/s41580-021-00375-5

Year: 2021

A self-sustaining endocytic-based loop promotes breast cancer plasticity leading to aggressiveness and pro-metastatic behavior

DOI: 10.1038/s41467-020-16836-y

Year: 2020

Comparison of StemPrintER, a novel biology-based genomic predictor of distant recurrence in breast cancer, with Oncotype DX in the TransATAC cohort.

DOI: 10.1200/jco.2020.38.15_suppl.1020

Year: 2020

Deliberation and Public Bioethics: A Test Case in Reproductive Genetics

DOI: 10.17454/PAM-1911

Year: 2020

Integration of the stem cell biology-based genomic tool, StemPrintER, with clinicopathological parameters for the prediction of distant recurrence in ER+/HER2- breast cancer (BC) patients.

DOI: 10.1200/jco.2020.38.15_suppl.1057

Year: 2020

A substrate-specific mTORC1 pathway underlies Birt-Hogg-Dubé syndrome

DOI: 10.1038/s41586-020-2444-0

Year: 2020

How Does Flow Cytometry Work?

What is Cell Culture?

How is Proteostasis Regulated?

What are Some Applications of Molecular Cloning?

How Does It Work?

What is Single Cell Sequencing?

Why is Catabolism Important?

Can the Pentose Phosphate Pathway Interact with Other Metabolic Pathways?

How Do Drugs Affect Neurotransmitters?

How Does Gene Expression Occur?

Partnered Content Networks

Relevant Topics